Search Results - "antiviral"

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal. by Sudhamshu Kc, Holly Murphy, Sameer Dixit, Apurva Rai, Bickram Pradhan, Marie Lagrange-Xelot, Niyanta Karki, Amélie Dureault, Ujjwal Karmacharya, Santosh Panthi, Nabin Tulachan, Prawchan Kc, Anjay Kc, Rajesh Rajbhandari, Andrew B Trotter, Jörg Gölz, Pierre Pradat, Christian Trépo, Philippe Creac'H

Connect to this object online.

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan by Saima Mushtaq, Tayyab Saeed Akhter, Amjad Khan, Aamir Sohail, Arshad Khan, Sobia Manzoor

Connect to this object online.

Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study by José Ríos, Víctor Sapena, Zoe Mariño, Jordi Bruix, Xavier Forns, Rosa Morros, María Reig, Ferran Torres, Caridad Pontes

Connect to this object online.

Descriptive epidemiology of novel influenza A (H1N1), Andhra Pradesh 2009-2010 by Ramesh R Allam, Manoj V Murhekar, Geetha P Tadi, Prasada R Udaragudi

Connect to this object online.

Time and Motion Study of Influenza Diagnostic Testing in a Community Pharmacy by Donald Klepser, Allison Dering-Anderson, Jacqueline Morse, Michael Klepser, Stephanie Klepser, Carolyn Corn

Connect to this object online.

Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen. by Antônio J S Gonçalves, Edson R A Oliveira, Simone M Costa, Marciano V Paes, Juliana F A Silva, Adriana S Azevedo, Marcio Mantuano-Barradas, Ana Cristina M A Nogueira, Cecília J Almeida, Ada M B Alves

Connect to this object online.

Trends in medicine utilisation in public and private healthcare facilities before and during COVID-19: a nationwide analysis of medicine procurement and sales data, 2018-2022 by Norazida Ab Rahman, Ee Vien Low, Audrey Huili Lim, Azzy Iyzati Ahmad Shanizza, See Wan Ho, Mardhiyah Kamal, Abdul Haniff Mohamad Yahaya, Sheamini Sivasampu

Connect to this object online.

Formulation of next-generation polyvalent vaccine candidates against three important poxviruses by targeting DNA-dependent RNA polymerase using an integrated immunoinformatics and... by Anuj Kumar, Mansi Dutt, Budheswar Dehury, Gustavo Sganzerla Martinez, Krishna Pal Singh, David J. Kelvin

Connect to this object online.

Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European... by Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz, Jeffrey V. Lazarus

Connect to this object online.

Retrospective study of hepatitis c virus relapse after treatment with sofosbuvir and daclatasvir with or without ribavirin by Mohamed DA Abd Alla, Amer AA Gomaa, Galal A Abou Farrag, Mohamed G Shikhroho, Walid M Mousa, Osama AM Mahmoud

Connect to this object online.

CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers by Caroline Schwarz, Raphael Schubert, Michael Schwarz, Angelika Schütz, Anika Jenke, David Bauer, Benjamin Steinwender, Enisa Gutic, Thomas Reiberger, Hans Haltmayer, Michael Gschwantler

Connect to this object online.

Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells by Yik Pui Tsang, Tianran Hao, Qingcheng Mao, Edward J. Kelly, Jashvant D. Unadkat

Connect to this object online.

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach by Ru Han, Shuyao Liang, Clément François, Samuel Aballea, Emilie Clay, Mondher Toumi

Connect to this object online.

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study by Rodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, Luigi Elio Adinolfi, Antonio Ascione, Giorgio Barbarini, Angelo Barlattani, Giuseppe Cariti, Raffaele Cozzolongo, Basilio Fimiani, Ruggiero Francavilla, Caterina Furlan, Giovanni Garrucciu, Vincenzo Iovinella, Luca Rinaldi, Massimo Marignani, Paola Begini, Valeria Pace Palitti, Adriano M Pellicelli, Gaetano Scifo, Antonio Facciorusso, Luca Giacomelli, Aashni Shah, Gaetano Bertino, Serena Perazzo, Giampaolo Bresci, Antonio Izzi

Connect to this object online.

Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners wit... by Jake Rance, Lise Lafferty, Carla Treloar, the SToP-C Study Group

Connect to this object online.

Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets by Janina Petkevičienė, Alexis Voeller, Eglė Čiupkevičienė, Devin Razavi-Shearer, Valentina Liakina, Ligita Jančorienė, Edita Kazėnaitė, Viačeslavas Zaksas, Gediminas Urbonas, Limas Kupčinskas

Connect to this object online.

Anti-infective Medicines Use in Children and Neonates With Pre-existing Kidney Dysfunction: A Systematic Review by Chiara Minotti, Elisa Barbieri, Denis Doni, Cristina Impieri, Carlo Giaquinto, Daniele Donà

Connect to this object online.

Comparing self-medication and medical supervised treatment before hospitalization among patients with Covid-19: A retrospective case-control study by Reza Khoshbakht, Mohammad Semsari Bonab, Homa Hajizadegan, Ehsan Tavakolizadeh Nooghabi, Atousa Ghorbani, Maryam Asgari, Alireza Neshani, Mahdis Ghavidel, Hamid Sadeghian

Connect to this object online.

Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate Hep... by Joshua Dawe, Megan Hughes, Shannon Christensen, Louisa Walsh, Jacqueline A. Richmond, Alisa Pedrana, Anna L. Wilkinson, Louise Owen, Joseph S. Doyle, on behalf of the EC Australia Partnership

Connect to this object online.

A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals. by Bobby Brooke Herrera, Donald J Hamel, Philip Oshun, Rolake Akinsola, Alani S Akanmu, Charlotte A Chang, Philomena Eromon, Onikepe Folarin, Kayode T Adeyemi, Christian T Happi, Yichen Lu, Folasade Ogunsola, Phyllis J Kanki

Connect to this object online.